新的氨酸法规,知情选择和发作风险
Heather Angus-Leppan1,2,3, Rachel Arkell4,5,6, Lance Watkins7,8
1University of East London, Stratford, E15 4LZ, UK. heather.angus-leppan@nhs.net.
Journal of neurology
|June 19, 2024
概括
英国新的氨酸法规危及患者的健康和自主权. 更严格的规则,特别是对于55岁以下的人来说,可能会导致突破性和死亡,并且无法充分监测患者除了生殖之外的结果.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 医学伦理 医学伦理
背景情况:
- 瓦尔酸盐是一种高度有效的药物,用于一般性,双相情感障碍和偏头痛预防.
- 目前的指导方针强调了酸的致病性和神经发育风险,只建议在其他治疗方法失败时使用它.
- 英国最近的监管变化限制了氨酸的使用,影响了患者的护理和治疗选择.
研究的目的:
- 审查氨酸法规背后的历史和证据.
- 分析英国最近对氨酸限制的伦理和法律影响.
- 提出建议,以改善患者的治疗结果和自主性.
主要方法:
- 对氨酸的疗效,致病性和监管史的文献综述.
- 分析英国的法规与医学伦理和法律原则 (蒙特哥马利原则,普通法) 相反.
- 检查与从酸转换相关的潜在患者风险.
主要成果:
- 英国2024年1月实施的法规限制了55岁以下人群对氨酸的使用.
- 在男性中限制氨酸的证据是基于有限的,非同行评审的数据.
- 据估计,大约有21000-28,000名英国患者从氨酸转换,可能会经历突破性发作,增加死亡风险.
结论:
- 目前英国的氨酸法规可能会侵犯患者的自主权和伦理医疗实践.
- 这些法规优先考虑胎儿风险,而不是更广泛的健康结果和患者的安全.
- 需要政府投资监测这些处方变化的影响,并提出建议以解决患者福利问题.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385
Antiepileptic Drugs: Potassium Channel Activators
169
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
169
Antiepileptic Drugs: Calcium Channel Blockers
369
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
369
Antiepileptic Drugs: Sodium Channel Blockers
508
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
508
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K


